CCCS(=O)(=O)N1CC(=O)N(c2cc(C)ccc2C)C(C)(C(=O)NC2CCCCCC2)C1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?